Article
In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates.
Antimicrobial agents and chemotherapy - 1 Sept 2011
Mishra Nagendra N, McKinnell James, Yeaman Michael R, Rubio Aileen, Nast Cynthia C, Chen Liang, Kreiswirth Barry N, Bayer Arnold S
Abstract excerpt
We investigated the hypothesis that methicillin-resistant Staphylococcus aureus (MRSA) isolates developing reduced susceptibilities to daptomycin (DAP; a calcium-dependent molecule acting as a cationic antimicrobial peptide [CAP]) may also coevolve reduced in vitro susceptibilities to host defense cationic antimicrobial peptides (HDPs). Ten isogenic pairs of clinical MRSA DAP-susceptible/DAP-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
